Stock Trading History of Warburg Pincus Partners Llc
The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider
Warburg Pincus Partners Llc since year 2005.
The trader's CIK number is
1322709.
At the time of this reporting, Warburg Pincus Partners Llc is the 10% Owner of
Sunesis Pharmaceuticals Inc
(stock ticker symbol
SNSS).
Note that in the past
Warburg Pincus Partners LLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by Warburg Pincus Partners Llc since 2005.
| Trade Date |
Symbol |
Company Name (Issuer) |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-05-30 | SNSS | Sunesis Pharmaceuticals Inc | Purchase | 677,200 | 4.43 | 2,999,996 |
| 2007-04-19 | EVVV | Ev3 Inc. | Sale | 6,000,000 | 19.00 | 114,000,000 |
| 2006-08-08 | KNL | Knoll Inc | Sale | 13,000,000 | 16.91 | 219,823,500 |
| 2006-03-20 | TDG | Transdigm Group Inc | Sale | 821,594 | 21.00 | 17,253,474 |
| 2006-03-17 | SNSS | Sunesis Pharmaceuticals Inc | Purchase | 805,153 | 6.21 | 5,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Warburg Pincus Partners Llc
(10% Owner of Sunesis Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
